Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study.
Olivier HanonJean-Sébastien VidalSylvain LehmannStéphanie BomboisBernadette AllinquantChristiane Baret-RoseJean-Marc TréluyerHendy AbdoulPatrick GeléChristine DelmaireFredéric BlancJean-François ManginLuc BuéeJacques TouchonJacques HugonBruno VellasEvelyne GalbrunAthanase BenetosGilles BerrutElena PaillaudDavid WallonGiovanni CastelnovoLisette Volpe-GillotMarc PaccalinPhilippe RobertOlivier GodefroyVincent CamusJoël BelminPierre VandelJean-Luc NovellaEmmanuelle DuronAnne-Sophie RigaudSusanna Schraen-MaschkeAudrey Gabellenull nullPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2022)
ratio that may detect patients with a low risk of conversion to dementia within 3 years.